Search results

  1. A

    Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19, Altay et al, 28 June 2021

    RC controlled studies with administration of NAC are always avoided because no patent profit will be acquired. But a lot of earlier cohort studies showed benefit of N-acetylcysteine (NAC) in acute COVID [1-Alam 2023- PMID: 37534078] . Antiviral H2S in particular has multiple targets for...
Back
Top